Stay updated on Pembrolizumab in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Lymphoma Clinical Trial page.
Latest updates to the Pembrolizumab in Lymphoma Clinical Trial page
- Check4 days agoChange DetectedThe website has added several new resources related to lymphoma and treatments, including links to MedlinePlus and DailyMed, while updating to revision v2.12.2.SummaryDifference4%
- Check11 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check18 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.6%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedDifference0.3%
- Check40 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.3%
- Check47 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.SummaryDifference0.7%
Stay in the know with updates to Pembrolizumab in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphoma Clinical Trial page.